Conventional wisdom says that the Kerry-Boxer clean energy bill faces a long uphill slog in the Senate against steep odds. But small changes are building beneath the surface of the news cycle, emerging as seven reasons for cautious optimism.
Key Republican support is already in place, beginning with Sen. Lindsey Graham, who took to the New Y ork Times editorial page offering full-throated support for passing clean energy legislation this year.














Oxford BioMedica, a leading gene therapy company, announced yesterday new data from the ongoing Phase I/II trial of ProSavin, its gene therapy for the treatment of Parkinson’s disease. All patients treated at the second dose level have completed their six-month assessments and have shown further improvement in motor function — up to 53% improvement in patients’ motor function, with an average uptick of 34%.. 













